A randomized double blind comparison of atosiban in patients undergoing IVF treatment

Human Reproduction

Volumn 29, Issue 12, 2014, Pages 2687-2694

  Ng, Ernest Hung Yu ^a   Li, Raymond Hang Wun ^a   Chen, Leining ^b   Lan, Vuong Thi Ngoc ^c   Tuong, Ho Manh ^d   Quan, Song ^e  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b GUANGDONG SECOND PROVINCIAL GENERAL HOSPITAL   (China)

^c UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^d VIETNAM NATIONAL UNIVERSITY   (Viet Nam)

^e SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

atosiban; IVF; live birth; uterine contraction

Indexed keywords

ATOSIBAN; CHORIONIC GONADOTROPIN; ESTRADIOL; HUMAN MENOPAUSAL GONADOTROPIN; PLACEBO; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; SODIUM CHLORIDE; ARGIPRESTOCIN; HORMONE ANTAGONIST;

ADULT; ARTERIAL TRUNK; ARTICLE; BIRTH RATE; BOLUS INJECTION; CHINA; CLEFT LIP; CLEFT PALATE; CONTINUOUS INFUSION; CONTROLLED STUDY; DANDY WALKER SYNDROME; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; ECTOPIC PREGNANCY; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; FOLLOW UP; HEART VENTRICLE SEPTUM DEFECT; HONG KONG; HUMAN; HYPOSPADIAS; LIVE BIRTH; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE PREGNANCY; NEWBORN DISEASE; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PREGNANCY RATE; PREGNANCY TEST; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION; SYNDACTYLY; UTERUS CONTRACTION; UTERUS MYOMA; VIET NAM; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; PREGNANCY; STATISTICAL MODEL;

DOUBLE-BLIND METHOD; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HORMONE ANTAGONISTS; HUMANS; LIVE BIRTH; LOGISTIC MODELS; PREGNANCY; VASOTOCIN;

EID: 84929650725     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu263     Document Type: Article

References (27)

1. Ayoubi JM, Epiney M, Brioschi PA, Fanchin R, Chardonnens D, De Ziegler D. Comparison of changes in uterine contraction frequency after ovulation in the menstrual cycle and in in vitro fertilization cycles. Fertil Steril. 2003; 79: 1101-1105
2. Bernabeu R, Roca M, Torres A, Ten J. Indomethacin effect on implantation rates in oocyte recipients. Hum Reprod. 2006; 21: 364-369
3. Blockeel C, Pierson R, Popovic-Todorovic B, Visnova HA, Garciá-Velasco HA, Mrázek M, Barri PN, Pierzynski P, Kuczynski W, Devroey P, et al. Effects of barusiban and atosiban on frequency of uterine contractions in the luteal phase after stimulation: a randomized placebo controlled trial. Hum Reprod. 2009; 24 (Suppl 1): i26
4. Centers for Disease Control and Prevention. 2013 Assisted Reproductive Technology Surveillance-United States, 2010. http://www.cdc.gov/mmwr/preview/mmwrhtml/ss6209a1.htm?s-cid=ss6209a1-e
5. Chou PY, Wu MH, Pan HA, Hung KH, Chang FM. Use of an oxytocin antagonist in in vitro fertilization-embryo transfer for women with repeated implantation failure: a retrospective study. Taiwan J Obstet Gynecol. 2011; 50: 136-140
6. Fanchin R. Uterine dynamics: impact on the human reproduction process. Reprod Biomed Online. 2009; 18 (Suppl 2): 57-62
7. Fanchin R, Righini C, Olivennes F, Taylor S, De Ziegler D, Frydman R. Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum Reprod. 1998; 13: 1968-1974
8. Ferraretti AP, Goossens V, Kupka M, Bhattacharya S, de Mouzon J, Castilla JA, Erb K, Korsak V, Nyboe Andersen A; 2013 European IVF-monitoring (EIM); Consortium, for The European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE. Hum Reprod. 2013; 28: 2318-2331
9. Fujiwara T, Togashi K, Yamaoka T, Nakai A, Kido A, Nishio S, Yamamoto T, Kitagaki H, Fujii S. Kinematics of the uterus: cine mode MR imaging. Radiographics. 2004; 24: e19
10. Kalmantis K, Loutradis D, Lymperopoulos E, Beretsos P, Bletsa R, Antsaklis A. Three Dimensional Power Doppler evaluation of human endometrium after administration of oxytocine receptor antagonist (OTR). in an IVF program. Arch Gynecol Obstet. 2012; 285: 265-270
11. Lan VT, Khang VN, Nhu GH, Tuong HM. Atosiban improves implantation and pregnancy rates in patients with repeated implantation failure. Reprod Biomed Online. 2012; 25: 254-260
12. Liang YL, Kuo TC, Hung KH, Chen TH, Wu MH. Oxytocin antagonist for repeated implantation failure and delay of delivery. Taiwan J Obstet Gynecol. 2009; 48: 314-316
13. Liedman R, Hansson SR, Howe D, Igidbashian S, McLeod A, Russell RJ, Akerlund M. Reproductive hormones in plasma over the menstrual cycle in primary dysmenorrhea compared with healthy subjects. Gynecol Endocrinol. 2008; 24: 508-513
14. Moon HS, Park SH, Lee JO, Kim KS, Joo BS. Treatment with piroxicambefore embryo transfer increases the pregnancy rate after in vitro fertilization and embryo transfer. Fertil Steril. 2004; 82: 816-820
15. Moraloglu O, Tonguc E, Var T, Zeyrek T, Batioglu S.Treatment with oxytocin antagonists before embryo transfer may increase implantation rates after IVF. Reprod Biomed Online. 2010; 21: 338-343
16. Pierson R, Deptuch JJ, Invik J, Klein BM, Breinholt V, Arce JC. Reproducibility of uterine contractility assessments based on transvaginal ultrasound cine-loop recordings. Hum Reprod. 2009; 24 (Suppl 1): i103
17. Pierzynski P, Gajda B, Smorag Z, Rasmussen AD, Kuczynski W. Effect of atosiban on rabbit embryo development and human sperm motility. Fertil Steril 2007a; 87: 1147-1152
18. Pierzynski P, Reinheimer TM, Kuczynski W. Oxytocin antagonists may improve infertility treatment. Fertil Steril 2007b; 88: e19-e22
19. Richter ON, Kubler K, Schmolling J, Kupka M, Reinsberg J, Ulrich U, van der Ven H, Wardelmann E, van der Ven K. Oxytocin receptor gene expression of estrogen-stimulated human myometrium in extracorporeally perfused non-pregnant uteri. Mol Hum Reprod. 2004; 10: 339-346
20. Somigliana E, Vercellini P, Daguati R, Pasin R, De Giorgi O, Crosignani PG. Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update. 2007; 13: 465-476
21. Tsatsaris V, Carbonne B, Cabrol D. Atosiban for preterm labour. Drugs. 2004; 64: 375-382
22. Tsirigotis M, Pelekanos M, Gilhespie S, Gregorakis S, Pistofidis G. Ritodrine use during the peri-implantation period reduces uterine contractility and improves implantation and pregnancy rates post-IVF. Hum Reprod. 2004; 15: (Abs. Bk 1), O-024, 10
23. Visnova H, Coroleu B, Piro M, Blockeel C, Mrazek M, Arce JC. Barusiban and atosiban for reduction of uterine contractions on day of embryo transfer do not alter the endocrine profile at time of implantation. Hum Reprod. 2009; 24 (Suppl 1): i178
24. Yoshino O, Hayashi T, Osuga Y, Orisaka M, Asada H, Okuda S, Hori M, Furuya M, Onuki H, Sadoshima Y, et al. Decreased pregnancy rate is linked to abnormal uterine peristalsis caused by intramural fibroids. Hum Reprod. 2010; 25: 2475-2479
25. Zhu L, Yanping Li Y, Xu A. Influence of controlled ovarian hyperstimulation on uterine peristalsis in infertile women. Hum Reprod. 2012; 27: 2684-2689
26. Zhu L, Xiao L, Che HS, Li YP, Liao JT. Uterine peristalsis exerts control over fluid migration after mock embryo transfer. Hum Reprod 2014a; 29: 279-285
27. Zhu L, Che HS, Xiao L, Li YP. Uterine peristalsis before embryo transfer affects the chance of clinical pregnancy in fresh and frozen-Thawed embryo transfer cycles. Hum Reprod 2014b; 29: 1238-1243